رفتن به محتوا

تداخل‌های دارویی

Alogliptin-pioglitazone + Somapacitan

شدت: متوسط

Alogliptin-pioglitazone and Somapacitan: moderate interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Growth hormone analogs can reduce insulin sensitivity and raise blood glucose, working against the effect of antidiabetic drugs. Glycemic control may worsen, especially at higher doses or in patients with diabetes.

معنای این تداخل به زبان ساده

Alogliptin-pioglitazone and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Alogliptin-pioglitazone belongs to Endocrine; Somapacitan belongs to Endocrine.

سطح شواهد: Moderate

چرا رخ می‌دهد

Growth hormone induces insulin resistance, opposing the glucose-lowering effect of pioglitazone and alogliptin.

اقدام لازم

Monitor blood glucose and HbA1c after starting somapacitan and increase antidiabetic therapy as needed.

از داروساز چه بپرسید

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alogliptin-pioglitazone و Somapacitan، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Alogliptin-pioglitazone with Somapacitan?

MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone analogs can reduce insulin sensitivity and raise blood glucose, working against the effect of antidiabetic drugs. Glycemic control may worsen, especially at higher doses or in patients with diabetes.

How serious is the interaction between Alogliptin-pioglitazone and Somapacitan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c after starting somapacitan and increase antidiabetic therapy as needed.

What other medicines interact with Alogliptin-pioglitazone?

MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود